Cardiovascular Medicine

Product Details:

Verquvo 2.5 (Vericiguat Film-Coated Tablets 2.5 mg) is a prescription medicine used to reduce the risk of cardiovascular death and hospitalization in adults with symptomatic chronic heart failure and ejection fraction less than 45%. Vericiguat, a soluble guanylate cyclase (sGC) stimulator, works by improving the function of the heart and blood vessels.

Key Features:

• Active Ingredient: Vericiguat 2.5 mg

• Form: Film-coated oral tablets

• Usage: For the treatment of chronic heart failure

• Prescription Required: Yes

• Storage: Store in a cool, dry place below 30°C. Keep away from moisture and direct sunlight.

Brand: Verquvo (Manufactured by Merck Sharp & Dohme Corp.)

Note: Use only as directed by a healthcare professional. Not recommended for use during pregnancy or in patients with severe liver impairment.

Product Details:

Verquvo 10 (Vericiguat 10 mg) is a prescription medicine used in the treatment of symptomatic chronic heart failure in adults with reduced ejection fraction. It is specifically indicated for patients who have recently experienced a worsening heart failure event requiring hospitalization or intravenous therapy. Vericiguat works by stimulating soluble guanylate cyclase (sGC), thereby improving cardiac function and reducing the risk of cardiovascular death and heart failure hospitalization.

Key Features:

• Contains Vericiguat 10 mg per tablet

• Film-coated for ease of swallowing

• Improves heart function and reduces risk of hospitalization

• Used in chronic heart failure with reduced ejection fraction (HFrEF)

• Taken orally, once daily, with food

Storage Conditions:
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Note:
Verquvo should be used under the supervision of a qualified healthcare professional. Dose and duration of treatment should be followed as per doctor’s advice.

Disclaimer:
This product is for B2B/institutional sale only. Not for direct consumer purchase. Prices may vary based on quantity and availability.

Product Details:

Verquvo 5 (Vericiguat 5mg) is a soluble guanylate cyclase (sGC) stimulator used for the treatment of symptomatic chronic heart failure in adults with reduced ejection fraction. It helps improve heart function by enhancing the nitric oxide-sGC-cGMP pathway, leading to improved vasodilation and reduced cardiac stress.

Indications:

• Chronic heart failure (HFrEF – Heart Failure with reduced Ejection Fraction)

• Patients stabilized after a recent episode of decompensation requiring hospitalization or intravenous diuretics

Key Features:

• Oral, once-daily tablet

• Film-coated for ease of swallowing

• Clinically proven to reduce the risk of cardiovascular death and heart failure hospitalization

Storage Instructions:
Store below 30°C. Protect from moisture and direct sunlight.

Caution:
To be sold by retail on the prescription of a registered medical practitioner only. Not for pediatric use.

Note: Please consult your healthcare provider before using this medication.

Product Details:

Xarelto 10 is an oral anticoagulant containing Rivaroxaban Ph. Eur. 10mg, a direct Factor Xa inhibitor. It is primarily used to prevent blood clots in patients undergoing hip or knee replacement surgery and for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Rivaroxaban works by reducing the ability of the blood to clot, thereby lowering the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Uses:

• Prevention of venous thromboembolism (VTE)

• Stroke prevention in non-valvular atrial fibrillation

• Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

Key Features:

• Trusted oral anticoagulant therapy

• Convenient once-daily dosing

• High bioavailability and rapid onset of action

• Clinically proven efficacy in reducing thrombotic events

Storage:
Store below 30°C. Protect from moisture and direct sunlight.

Note:
To be sold by retail on the prescription of a Registered Medical Practitioner only.

Product Details:

Xarelto 15 (Rivaroxaban Ph. Eur. 15 mg) is an oral anticoagulant used to prevent and treat blood clots. It belongs to a class of medications known as direct Factor Xa inhibitors and is commonly prescribed for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

Key Features:

• Composition: Rivaroxaban Ph. Eur. 15 mg

• Form: Film-coated tablet

• Packaging: Strip/Box as per requirement

• Usage: Prescription medicine

• Administration: Oral

• Storage: Store below 30°C in a dry place, away from direct sunlight

Indications:

• Treatment of DVT and PE

• Prevention of recurrent DVT and PE

• Prevention of stroke in atrial fibrillation (non-valvular)

Manufacturer: [Mention Manufacturer Name, if required]

Note: This product should be used under the supervision of a qualified healthcare professional.

Product Details:

Xarelto 15 (Rivaroxaban 15 mg) is an oral anticoagulant used for the prevention and treatment of blood clots. It belongs to a class of medications called direct Factor Xa inhibitors and is commonly prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevent recurrence.

Key Features:

• Trusted anticoagulant therapy

• Rapid onset of action

• Fixed dosing without routine coagulation monitoring

• Improves patient compliance due to once-daily or twice-daily dosing (as prescribed)

Usage:
Used under medical supervision for:

• Deep Vein Thrombosis (DVT)

• Pulmonary Embolism (PE)

• Prevention of stroke in patients with atrial fibrillation

• Post-operative thromboprophylaxis following hip or knee replacement surgery

Storage:
Store in a cool and dry place, below 25°C. Protect from moisture and direct sunlight.

Note:
This medication should be used under the supervision of a qualified healthcare professional. Dosage and duration depend on the condition and patient response.

For Bulk Orders, Exports, or Distribution Enquiries – Contact Us Now!

Product Details:

Xarelto 2.5 (Rivaroxaban Ph. Eur. 2.5 mg) is an oral anticoagulant used to prevent blood clots and reduce the risk of cardiovascular events in patients with a history of acute coronary syndrome (ACS) or peripheral artery disease (PAD). Rivaroxaban is a selective direct Factor Xa inhibitor, which helps prevent the formation of thrombin and thrombi in the blood.

Key Uses:

• Prevention of atherothrombotic events in adult patients with ACS or PAD

• Used alongside antiplatelet therapy such as aspirin or clopidogrel

• Helps in reducing risk of stroke, heart attack, and other clot-related conditions

Key Features:

• Clinically proven effectiveness

• Convenient once or twice daily dosing (as per indication)

• High-quality formulation as per European Pharmacopoeia standards

• Manufactured under GMP-certified facilities

Note: Use only under medical supervision. Not for self-medication.